High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.

Autor: Metzelder, S K1, Schroeder, T2, Finck, A3, Scholl, S4, Fey, M5, Götze, K6, Linn, Y C7, Kröger, M8, Reiter, A9, Salih, H R10, Heinicke, T11, Stuhlmann, R12, Müller, L13, Giagounidis, A14, Meyer, R G15, Brugger, W16, Vöhringer, M17, Dreger, P18, Mori, M19, Basara, N20
Zdroj: Leukemia (08876924). Nov2012, Vol. 26 Issue 11, p2353-2359. 7p. 2 Charts, 2 Graphs.
Databáze: Academic Search Ultimate